| Bioactivity | Zaloglanstat (ISC-27864) is the inhibitor of the microsomal prostaglandin E synthase-1 (mPGES-1), and can be used to study asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases, etc[1]. | ||||||||||||
| Name | Zaloglanstat | ||||||||||||
| CAS | 1513852-12-4 | ||||||||||||
| Formula | C21H20ClF3N4O2 | ||||||||||||
| Molar Mass | 452.86 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Di Micco S, Terracciano S, Ruggiero D, Potenza M, Vaccaro MC, Fischer K, Werz O, Bruno I, Bifulco G. Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition. Front Chem. 2021 May 7;9:676631. |
Zaloglanstat
CAS: 1513852-12-4 F: C21H20ClF3N4O2 W: 452.86
Zaloglanstat (ISC-27864) is the inhibitor of the microsomal prostaglandin E synthase-1 (mPGES-1), and can be used to stu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.